S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Onconova Announces Presentation of Rigosertib Clinical Data in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting (2013/11/7)|
|Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results (2013/11/12)|
|Onconova Therapeutics, Inc. Reports Second Quarter 2013 Financial and Operational Results (2013/9/6)|
|SEMAFO Releases Third Quarter 2013 Results (2013/11/13)|
|Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes (2013/11/7)|
|SEMAFO's Delineation Drilling at Siou Extends Mineralization: Results Include 10.68 g/t Au Over 12 Meters and 23.88 g/t Au Over 3.5 Meters (2013/8/1)|
|TELUS reports second quarter 2013 results ()|
|TELUS reports second quarter 2013 results (2013/8/8)|
|Frontier Rare Earths Announces Filing of Q2 2013 MD&A and Financial Statements ()|
|CUC Announces Third Quarter Results for the Period Ended September 30th, 2013 ()|
Click above to view more mutual fund data and stats for md - Midland Exploration, Inc..